A Study to Determine the Number of Participants With Rheumatoid Arthritis (RA) Who Meet the Requirements for Treatment With Anti-Tumor Necrosis Factor α (TNFα) in a General Hospital Setting in Korea
Clinical trial NCT01294722 · COMPLETED
Trial details
- NCT number
- NCT01294722
- Sponsor
- Janssen Korea, Ltd., Korea
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2011-12-01
- Primary completion
- 2012-08-01
- Enrollment
- 1700
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.